Prism BioLab

Japan
Fujisawa, Kanagawa, Japan, 251-8555

Company profile

Prism BioLab company profile

PRISM provider of a therapeutic treatment for non-oncology indications.The company develops therapeutic agents that are used to cure pulmonary fibrosis, cancer and incurable diseases.

Business identity

Phone number
+81 04-6653-8383
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2006-11-02

Headquarters

Postal code
251-8555
Country code
JP
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
5
Total equity funding
$27.5M
Last funding
Series C / $10.2M / 2024-01-24
Last equity funding
Series C / $10.2M
Investors
14
Lead investors
3
Founders
1
Articles
32

Founders and investors

Founders

Takehara Dai

Lead investors

DBJ CapitalEisaiInnovation Network Corporation of Japan

Investors

Daiwa Corporate InvestmentEisaiEli LillyJAFCOWM Partners